Chemoinformaics analysis of BETA-CYCLOCOSTUNOLIDE
| Molecular Weight | 232.323 | nRot | 0 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 18 |
| Exact Molecular Weight | 232.146 | nRing | 3 |
| Solubility: LogS | -3.821 | nHRing | 1 |
| Solubility: LogP | 3.114 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 39.9899 |
| nHD | 0 | BPOL | 22.6681 |
| QED | 0.364 |
| Synth | 4.272 |
| Natural Product Likeliness | 3.424 |
| NR-PPAR-gamma | 0.222 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.64 |
| MDCK | 0.0000247 |
| BBB | 0.829 |
| PPB | 0.774205 |
| VDSS | 1.146 |
| FU | 0.210058 |
| CYP1A2-inh | 0.406 |
| CYP1A2-sub | 0.645 |
| CYP2c19-inh | 0.323 |
| CYP2c19-sub | 0.497 |
| CYP2c9-inh | 0.288 |
| CYP2c9-sub | 0.092 |
| CYP2d6-inh | 0.641 |
| CYP2d6-sub | 0.544 |
| CYP3a4-inh | 0.28 |
| CYP3a4-sub | 0.227 |
| CL | 11.814 |
| T12 | 0.061 |
| hERG | 0.01 |
| Ames | 0.076 |
| ROA | 0.851 |
| SkinSen | 0.279 |
| Carcinogencity | 0.274 |
| EI | 0.314 |
| Respiratory | 0.953 |
| NR-Aromatase | 0.23 |
| Antiviral | Yes |
| Prediction | 0.844386 |